Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...
AJMC®: How is COPD definitively diagnosed in clinical practice, and how does this disease create a clinical burden on patients and caregivers? Dr Rali: COPD diagnosis requires both clinical context ...
David Mannino is co-founder and chief medical officer of the COPD Foundation. He's an internal medicine doctor with a specialty in pulmonary, critical care, and sleep medicine at University of ...
Chronic Obstructive Pulmonary Disease companies are Afimmune, Allakos, Amgen/AstraZeneca, Arrowhead Pharmaceuticals, Zydus Lifesciences, Astellas, AstraZeneca. ALBANY, NY, UNITED STATES, December 18, ...
At the ERS 2025 Congress, the world’s largest annual meeting on respiratory diseases, attended by international experts, one of the hot topics in pulmonary medicine was discussed this year—the ...
If you or someone close to you suffers from chronic shortness of breath, persistent cough, and reduced physical fitness, there is a chance it may be COPD. This is a serious lung disease affecting ...
The natriuretic peptides, specifically brain natriuretic peptide (BNP), are the most specific and applicable laboratory tests available to establish fluid overload associated with HF. 9 BNP is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results